Venous Occlusion Clinical Trial
Official title:
Evaluation of the Surfacer System Approach to Central Venous Access
Pre-market Investigational device exemption study evaluating the safety and efficacy of the Surfacer System to facilitate stable upper body central venous access suitable for any conventional catheter.
This prospective, single arm, multi-center study is to demonstrate the safety and efficacy of the Surfacer System. Safety will be evaluated based on the overall rate of acute complications using the study device as compared to historical rates of device/procedure related safety events using conventional central venous access methods. Efficacy will be evaluated by the rate of transient successful central venous accesses created by the study device. A total of 30 patients are planned to be enrolled, with 10 patients initially following review of safety data. Duration expected to be through 7 days. A minimum of 3 sites will participate in the study in the United States. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05409976 -
The GORE® VIAFORT Vascular Stent IVC Study
|
N/A | |
Recruiting |
NCT02331511 -
Prevention of Venous Obstruction After Implantation of Cardiac Pacemaker and Defibrillator
|
N/A | |
Terminated |
NCT02241343 -
Venous Occlusion and Limb Swelling
|
N/A | |
Active, not recruiting |
NCT04540302 -
The Merit WRAPSODY AV Access Efficacy Study (WAVE)
|
N/A | |
Not yet recruiting |
NCT06096142 -
The Solaris DE Endoprosthesis for the Treatment of AV Access Stenosis or Occlusion
|
N/A | |
Withdrawn |
NCT04541576 -
The Merit WRAPSODY Central Feasibility Study
|
N/A | |
Recruiting |
NCT05489588 -
The GORE® VIAFORT Vascular Stent Iliofemoral Study
|
N/A | |
Recruiting |
NCT05062291 -
Merit WRAPSODY™ Endoprosthesis for Treatment of Stenosis or Occlusion (WRAP)
|
||
Completed |
NCT03644017 -
The Merit WRAPSODY™ Endovascular Stent Graft
|
N/A | |
Recruiting |
NCT04995432 -
Non Contrast MRI in Lower Extremity
|